tailieunhanh - A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis

This study evaluated two doses of etoricoxib (60 and 90 mg) vs. naproxen 1000 mg in subjects with ankylosing spondylitis (AS). Both doses of etoricoxib were non-inferior to naproxen. All treatments were well tolerated. Etoricoxib 60 and 90 mg effectively control pain in patients with AS, with 60 mg once daily as the lowest effective dose for most patients. |

TÀI LIỆU MỚI ĐĂNG
28    158    1    23-12-2024
13    157    1    23-12-2024
6    139    0    23-12-2024
5    128    0    23-12-2024
64    132    0    23-12-2024
18    129    0    23-12-2024